MIRA INFORM REPORT

 

 

Report Date :

02.05.2012

 

IDENTIFICATION DETAILS

 

Name :

STERILE INDIA PRIVATE LIMITED (w.e.f. 07.07.2010)

 

 

Formerly Known As :

UNIWAYS LABORATORIES INDIA PRIVATE LIMITED

 

 

Registered Office :

1075, 4th Floor, Onkar Bhawan, Bhagirath Palace, Chandhi Chowk, Delhi – 110006

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

05.06.1989

 

 

Com. Reg. No.:

55-036517

 

 

Capital Investment / Paid-up Capital :

Rs.0.102 Million

 

 

CIN No.:

[Company Identification No.]

U74899DL1989PTC036517

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

DELU03892A

 

 

PAN No.:

[Permanent Account No.]

AAACU5331M

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Sterile Active pharmaceutical Ingredients.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ca (13)

 

RATING

STATUS

PROPOSED CREDIT LINE

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

 

Status :

No Business Activity

 

 

Payment Behaviour :

Unknown

 

 

Litigation :

Clear

 

 

Comments :

Though the company was incorporated in the year 1989, it has yet not started its commercial production. Payments are unknown.

 

The company can be considered for business dealings on a safe and secured trade terms and conditions.

 

   

Profit and Loss account of the company is not available .

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30, 2011

 

Country Name

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

 

 


 

LOCATIONS

 

Registered Office :

1075, 4th Floor, Onkar Bhawan, Bhagirath Palace, Chandhi Chowk, Delhi – 110006, India

Tel. No.:

91-11-27357015

Fax No.:

91-11-27357015

E-Mail :

sales@sterileindia.com

info@sterileindia.com

sales@mahimalife.com

Website :

www.sterileindia.com

 

 

Corporate Office :

1015, 10th Floor, D Mall, Netaji Subhash Place, Pitampura, New Delhi - 110 034, India

 

 

Factory  :

Sector -56, Hsiidc, Kundli – Plot No-100, Phase – IV, Sonepat – 131028, Haryana, India 

 

 

DIRECTORS

 

As on 30.09.2011

 

Name :

Mr. Sanjeev Goel

Designation :

Director

Address :

78/12, Jain Sthana Ganaur, Mandi, Sonipat – 131001, Haryana, India

Date of Birth/Age :

12.02.1969

Date of Appointment :

04.06.2011

DIN No.:

00370189

 

Other directorship :

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U51397DL1997PTC084824

OSHO INTERNATIONAL PRIVATE LIMITED

Director

31/01/1997

31/01/1997

8/1/2008

Active

NO

2

U51311DL1996PTC083943

MAHIMA LIFESCIENCES PRIVATE LIMITED

Director

13/03/1997

13/03/1997

8/6/2011

Active

NO

3

U74899DL1989PTC036517

STERILE INDIA PRIVATE LIMITED

Director

4/6/2011

7/4/2007

-

Active

NO

4

U17121DL2007PTC168198

SHREE RADHEY KRISHNA SPINNERS PRIVATE LIMITED

Director

21/06/2010

21/06/2010

-

Active

NO

5

U51909WB2010PTC141866

FUSION VINTRADE PRIVATE LIMITED

Director

30/03/2011

30/03/2011

-

Active

NO

6

U51909WB2008PTC123294

ENCORD COMMERCIAL PRIVATE LIMITED

Director

21/07/2011

21/07/2011

-

Active

NO

7

U51909WB2008PTC123277

VERSATILE VINIMAY PRIVATE LIMITED

Director

21/07/2011

21/07/2011

-

Active

NO

 

 

Name :

Mr. Prem Chand Goel

Designation :

Director

Address :

B-37, Maharana Partap Enclave, Pitampura, Delhi – 110034, India

Date of Birth/Age :

18.02.1944

Date of Appointment :

31.10.2009

DIN No.:

02822907

 

Other directorship :

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U74899DL1989PTC036517

STERILE INDIA PRIVATE LIMITED

Director

30/09/2010

31/10/2009

-

Active

NO

2

U51909WB2010PTC141866

FUSION VINTRADE PRIVATE LIMITED

Director

30/03/2011

30/03/2011

-

Active

NO

3

U51109DL2008PTC184847

REDHERRING SANITARYWARE PRIVATE LIMITED

Director

30/09/2011

19/07/2011

-

Active

NO

4

U32204DL2007PTC169768

GATIMAAN DEVELOPERS PRIVATE LIMITED

Director

29/09/2011

29/07/2011

-

Active

NO

5

U17296DL2007PTC166770

CHAUDHARY CLOTHING PRIVATE LIMITED

Director

3/8/2011

3/8/2011

-

Active

NO

6

U17121DL2007PTC166816

CHAUDHARY APPARELS PRIVATE LIMITED

Director

5/8/2011

5/8/2011

-

Active

NO

7

U51909WB2009PTC133355

CALENDULA DEALCOM PRIVATE LIMITED

Director

14/12/2011

14/12/2011

-

Active

NO

 

 

Name :

Mr. Pavel Garg

Designation :

Director

Address :

House No.32, Sector -15, Sonipat – 131001, Haryana, India

Date of Birth/Age :

01.12.1968

Date of Appointment :

05.06.1989

DIN No.:

00085167

 

Other directorship :

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U74899DL1989PTC036517

STERILE INDIA PRIVATE LIMITED

Director

5/6/1989

5/6/1989

-

Active

NO

2

U74999DL2003PTC119576

CAPITAL INSURANCE BROKERS PRIVATE LIMITED

Managing director

26/03/2003

26/03/2003

1/2/2011

Active

NO

3

U24239DL2004PTC127727

PASSION PHARMA PRIVATE LIMITED

Director

20/07/2004

20/07/2004

-

Active

NO

4

U24239DL2004PTC129776

POPULAR BIOTECH PRIVATE LIMITED

Director

8/10/2004

8/10/2004

-

Active

NO

5

U26942DL1990PTC041941

MUDIT CEMENT Private LIMITED

Director

14/02/2005

14/02/2005

28/05/2007

Active

NO

6

L65993DL1989PLC035635

MUDIT FINLEASE LIMITED

Managing director

6/11/2006

14/02/2005

-

Active

NO

7

U72200DL2005PTC140688

ALPINE COMPUTECH PRIVATE LIMITED

Director

13/09/2005

13/09/2005

1/6/2009

Active

NO

8

U18101DL2002PTC115827

HARE KRISHNA EXOTIC PRIVATE LIMITED

Director

4/10/2005

4/10/2005

-

Active

NO

9

U24233DL2004PTC131058

SHIVA MEDICHEM EXPORTS PRIVATE LIMITED

Director

4/10/2005

4/10/2005

-

Active

NO

10

U55101DL2006PTC146521

CLOUDS HOTEL PRIVATE LIMITED

Director

17/02/2006

17/02/2006

-

Active

NO

11

U72900DL2007PTC157429

ALTA VISTA INFO SOLUTIONS PRIVATE LIMITED

Director

4/1/2007

4/1/2007

-

Active

NO

12

U51909DL2009PTC187597

MEDITRUST HEALTHCARE PRIVATE LIMITED

Director

13/02/2009

13/02/2009

-

Active

NO

13

U74899DL1995PTC064785

AQUARIUS SECURITIES PRIVATE LIMITED

Director

15/04/2010

15/04/2010

1/10/2011

Active

NO

14

U55101DL2011PTC227662

BLOOMS HOTEL PRIVATE LIMITED

Director

18/11/2011

18/11/2011

-

Active

NO

15

U74899DL1981PTC012922

COMBITIC GLOBAL CAPLET PRIVATE LIMITED

Additional director

14/02/2012

14/02/2012

-

Active

NO

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2011

 

Names of Shareholders

 

No. of Shares

Pavel Garg

 

540

Sanheev Goel

 

480

Total

 

1020

 

As on 30.09.2011

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Sterile Active pharmaceutical Ingredients.

 

 

Product :

·         Sterile PPI’s Products

·         Cephalosporins

·         Penicillins

·         General Products

·         Carbapenems

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available 

 

 

Bankers :

HDFC Bank Limited, HDFC Bank House Senapati Bapat Marg, Lower Parel (West), Mumbai - 400013, Maharashtra, India

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Mittal Bansal and Associates

Chartered Accountants

Address :

302-303, 2nd Floor, S-524, Vikas Marg, Shakarpur, Delhi – 110092, India

PAN.:

AALFM7202R

 


 

CAPITAL STRUCTURE

 

As on 31.03.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

200000

Equity Shares

Rs.100/- each

Rs.20.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1020

Equity Shares

Rs.100/- each

Rs.0.102 Million

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

0.102

0.102

0.102

2] Share Application Money

93.506

46.206

15.752

3] Reserves & Surplus

0.000

0.000

0.000

4] (Accumulated Losses)

(0.090)

(0.090)

(0.090)

NETWORTH

93.518

46.218

15.764

LOAN FUNDS

 

 

 

1] Secured Loans

0.000

0.000

0.000

2] Unsecured Loans

0.000

0.000

0.000

TOTAL BORROWING

0.000

0.000

0.000

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

93.518

46.218

15.764

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

85.753

10.023

0.000

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

0.000

0.000

0.000

 

Sundry Debtors

0.000

0.000

0.000

 

Cash & Bank Balances

2.549

8.295

0.221

 

Other Current Assets

4.338

0.184

0.000

 

Loans & Advances

8.592

27.919

15.380

Total Current Assets

15.479

36.398

15.601

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

8.409

0.390

0.000

 

Other Current Liabilities

0.051

0.053

0.010

 

Provisions

0.000

0.000

0.000

Total Current Liabilities

8.460

0.443

0.010

Net Current Assets

7.019

35.955

15.591

 

 

 

 

MISCELLANEOUS EXPENSES

0.746

0.240

0.173

 

 

 

 

TOTAL

93.518

46.218

15.764

 


 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

Debt Equity Ratio

(Total Liability/Networth)

 

0.09

0.01

0.00

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.83

82.16

1560.10

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Check List by Info Agents

Available in Report (Yes / No)

1) Year of Establishment

Yes

2) Locality of the firm

Yes

3) Constitutions of the firm

Yes

4) Premises details

No

5) Type of Business

Yes

6) Line of Business•

Yes

7) Promoter’s background

Yes

8) No. of employees

No

9) Name of person contacted

No

10) Designation of contact person

No

11) Turnover of firm for last two years

No

12) Profitability for last three years

No 

13) Reasons for variation <> 20%

-

14) Estimation for coming financial year

No

15) Capital in the business

Yes

16) Details of sister concerns

No

17) Major suppliers

No

18) Major customers

No

19) Payments terms

No

20) Export / Import details (if applicable)

No

21) Market information

--

22) Litigations that the firm / promoter

--

23) Banking Details

Yes

24) Banking facility details

No

25) Conduct of the banking account

--

26) Buyer visit details

--

27) Financials, if provided

Yes

28) Incorporation details, if applicable

Yes

29) Last accounts filed at ROC

Yes

30) Major Shareholders, if available

Yes

 


Financial Results

 

During the year, the company has incurred a loss as the commercial production of the Company has not started. The directors expect better performance next year.

 

 

Bankers Charges Report as per Registry

 

Corporate identity number of the company

U74899DL1989PTC036517

Name of the company

STERILE INDIA PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

1075, 4th Floor, Onkar Bhawan, Bhagirath Palace, Chandhi Chowk, Delhi – 110006, India

Email : sales@mahimalife.com   

This form is for

Modification of charge

Charge identification (ID) number of the charge to be modified

10319944

Type of charge

Immovable property

Particular of charge holder

HDFC Bank Limited, HDFC Bank Housesenapati Bapat Marg, Lower Parel west, Mumbai - 400013, Maharashtra, India

Nature of instrument creating charge

Memorandum recording past transactions of creation of mortgage by delivery of title deeds

Date of instrument Creating the charge

01.12.2011

Amount secured by the charge

Rs. 100.000 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest

Interest at the rate as may be communicated by the Bank from time to time.

 

Terms of Repayment

On demand.

 

Margin

As may be stipulated by the Bank from time to time.

Extent and Operation of the charge

The Company created an equitable mortgage by way of deposit of title deeds in respect of its immovable properties as security for the due repayment of Rs.100.000 Millions by the Company including principal amount of the Facility, interest, liquidated damages, costs, charges and expenses etc.

 

Others

NIL

Short particulars of the property or asset(s) charged (including complete address and location of the property)

Industrial Plot No. 100, admeasuring 4050 sq. mtrs, Sectors - 56, in Industrial Estate Kundli

Particulars of the present modification

The Company created a mortgage by deposit of title deeds in respect of its immovable property being lying and situated at Industrial Plot No. 100, admeasuring 4050 sq. mtrs, Sectors - 56, in Industrial Estate Kundli as further security for repayment of monies due and payable under credit facilities of Rs. 100.000 Millions sanctioned by the Bank to the Company.

 

FIXED ASSETS

 

·         Generator Set

·         Scrap Container

·         Building

 

 

WEBSITES:

 

PROFILE:

 

Their facilities deploy state-of-the-art technologies and automated facilities that ensure the highest levels of process integrity and product quality. Their plants (for both crystallisation and lyophillisation) has been laid down as per guidelines of USFDA/EDQM, cGMP standard, fabrication and support systems. Infrastructure meets the world-class standards.

 

The facility is having three isolated manufacturing blocks for aseptic process for Penicillins, Cephalosporins and other drugs with high capacity to meet the increasing demand of the drugs domestically as well as Internationally. It is one of the leading unit in India in the category of sterile dry powder for injection Their facilities have fully independent Quality Control departments with numbers of sophisticated equipment such as HPLC, GC, titrators FTIR and UV spectrometer to ensure conformance to stringent quality standards. Well qualified and experienced technocrats carryout testing of drugs.  Quality has always been a strong part of their group. Their quality responsibility covers all aspects including product quality, operational quality, environmental quality and finally a good quality of life for their people. The Company has setup a very strong Regulatory Division for all kinds of dossier support and is committed to highest standards of quality. They endeavors to build a sustainable organizational eco-system where one is constantly motivated to attain new heights and privilege to discover new avenues for growth.

 

They quest to balance environmental impact and economic interest in all their business activities.They committed to the development of the society, culture and economy, they dutifully observe laws, demonstrate high ethical standards and endeavor to preserve the environment.

 

The Company has a clear vision of fully integrated Pharmaceutical Company providing world class pharmaceutical products and services

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.52.51

UK Pound

1

Rs.85.49

Euro

1

Rs.69.61

 

 

INFORMATION DETAILS

 

Report Prepared by :

DPK

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

2

PAID-UP CAPITAL

1~10

2

OPERATING SCALE

1~10

2

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

2

--PROFITABILIRY

1~10

1

--LIQUIDITY

1~10

1

--LEVERAGE

1~10

1

--RESERVES

1~10

1

--CREDIT LINES

1~10

1

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

13

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.